Moderna (MRNA) Change in Acquisitions & Divestments (2018 - 2026)

Moderna has reported Change in Acquisitions & Divestments for 9 years, with the latest figure at $710.0 million in Q2 2026.

• Change in Acquisitions & Divestments for Q2 2026 came in at $710.0 million, down 52.38% year-over-year; the trailing twelve-month figure through Jun 2026 was $3.6 billion (down 34.29% YoY), and the FY2025 annual result was $5.6 billion, changed 0.02% from the prior year.
• Change in Acquisitions & Divestments retreated to $710.0 million in Q2 2026, from $732.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $2.0 billion in Q2 2024 and troughed at $412.0 million in Q3 2022.
• A 5-year average of $1.2 billion and a median of $1.2 billion in 2022 frame the typical range for Change in Acquisitions & Divestments.
• The widest annual swing landed in 2022, when Change in Acquisitions & Divestments soared 306.19%; it then tumbled 62.13% in 2026.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $630.0 million in 2022, then surged by 37.14% to $864.0 million in 2023, then climbed by 5.79% to $914.0 million in 2024, then increased by 1.64% to $929.0 million in 2025, then retreated by 23.57% to $710.0 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $710.0 million in Q2 2026, $732.0 million in Q1 2026, and $929.0 million in Q4 2025.